NS · Healthcare

Welcure Drugs & Pharmaceuticals Ltd (524661)

Pharmaceuticals & Biotechnology

Welcure Drugs & Pharmaceuticals Ltd (524661) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $333.70M, P/E ratio is -6.75, net margin is -59.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 524661

Market cap

$333.70M

P/E ratio

-6.75

Net margin

-59.8%

Welcure Drugs & Pharmaceuticals Ltd (524661) — FAQ

What is Welcure Drugs & Pharmaceuticals Ltd's market cap?

Welcure Drugs & Pharmaceuticals Ltd (524661) has a reported market cap of $333.70M (data as of 2026-07-10).

What is 524661's P/E ratio?

The price-to-earnings (P/E) ratio for Welcure Drugs & Pharmaceuticals Ltd (524661) is -6.75 (data as of 2026-07-10).

Does Welcure Drugs & Pharmaceuticals Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Welcure Drugs & Pharmaceuticals Ltd (524661). Check the MyAverix Finance app for the latest dividend data.

What sector is Welcure Drugs & Pharmaceuticals Ltd in?

Welcure Drugs & Pharmaceuticals Ltd (524661) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 524661 listed on?

524661 is listed on NS.

What is Welcure Drugs & Pharmaceuticals Ltd's net margin?

Welcure Drugs & Pharmaceuticals Ltd (524661) reports a net margin of -59.8% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)